0001472343-16-000238.txt : 20161110 0001472343-16-000238.hdr.sgml : 20161110 20161110161633 ACCESSION NUMBER: 0001472343-16-000238 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161110 FILED AS OF DATE: 20161110 DATE AS OF CHANGE: 20161110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Roka BioScience, Inc. CENTRAL INDEX KEY: 0001472343 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 270881542 STATE OF INCORPORATION: DE FISCAL YEAR END: 1216 BUSINESS ADDRESS: STREET 1: 20 INDEPENDENCE BOULEVARD CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-605-4700 MAIL ADDRESS: STREET 1: 20 INDEPENDENCE BOULEVARD CITY: WARREN STATE: NJ ZIP: 07059 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boesgaard Lars CENTRAL INDEX KEY: 0001403893 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36538 FILM NUMBER: 161988245 MAIL ADDRESS: STREET 1: C/O ROKA BIOSCIENCE, INC. STREET 2: 20 INDEPENDENCE BOULEVARD CITY: WARREN STATE: NJ ZIP: 07059 4 1 wf-form4_147881257960648.xml FORM 4 X0306 4 2016-11-10 0 0001472343 Roka BioScience, Inc. ROKA 0001403893 Boesgaard Lars 20 INDEPENDENCE BLVD WARREN NJ 07059 0 1 0 0 Vice President, CFO Common Stock, $0.001 par value per share 2016-11-10 4 C 0 3572 7 A 8938 D Series A Convertible Preferred Stock 2016-11-10 4 C 0 25 0 D Common stock, par value $0.001 per share 3572.0 0 D Reporting person's Series A Convertible Preferred Stock, par value $0.001 per share (the "Series A Preferred Shares") automatically converted into shares of the Company's common stock, par value $0.001 (the "Common Shares") at a conversion price of $7.00 per share resulting in his acquisition of 3,572 Common Shares. Common Shares disclosed reflect the October 11, 2016, 10 for 1 reverse stock split of the Company's Common Shares. The Series A Preferred Shares were adjusted proportionately and consequently, each share of Preferred Stock became convertible into approximately 143 shares of common stock. The Series A Preferred Shares automatically converted, upon receipt of Company shareholder approval and had no expiration date. /s/ Corey Swanson, attorney-in-fact 2016-11-10